Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma	Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, alveolar soft part sarcoma, myomatous neoplasm, neoplasm, sarcoma	Recruiting	Phase 2	2026-04-23		NCT07548177

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	88

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Cancer Hospital	Beijing	China	208
Harbin Medical University Cancer Hospital	Harbin	China	102
Henan Cancer Hospital	Zhengzhou	China	76
Shandong First Medical University Affiliated Tumor Hospital	Jinan	China	4
Shanghai General Hospital	Shanghai	China	59
Sun Yat-sen University Cancer Center	Guangdong	China	1
The First Affiliated Hospital of Army Medical University of the People's Liberation Army of China	Chongqing	China	1
The First Hospital of Jilin University	Changchun	China	110
The Second Affiliated Hospital, Zhejiang University School of Medicine.	Hangzhou	China	1
Tianjin Medical University Cancer Institute & Hospital	Tianjin	China	58
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	37
West China Hospital of Sichuan University	Chengdu	China	117
Xiangya Hospital of Central South University	Changsha	China	47
Xinjiang Medical University Affiliated Cancer Hospital	Ürümqi	China	2
Zhejiang Cancer Hospital	Hangzhou	China	164